Literature DB >> 23856551

[Treatment of Dupuytren's contracture by collagenase injection].

R Foissac1, O Camuzard, P Dumas, C Dumontier, B Chignon-Sicard.   

Abstract

Dupuytren's disease is a disorder of the palmar aponeurosis responsible for apparition of pathological collagen cords that will gradually lead to a digital retraction. These cords cause functional disability to the hand with a real handicap for the patient. No curative treatment exists currently in this disease. Injections of collagenase from Clostridium histolyticum cause lysis of the collagen present in the cords and cause an interruption of the palmar cord. It is a new treatment in the management of Dupuytren's disease. The use of collagenase injection in the treatment of palmar form of Dupuytren's disease gives good results in the short and medium terms. It is a simple, minimally invasive treatment, several studies have proven its effectiveness and it approximates percutaneous needle fasciotomy in its easy use and its indications. Patients should be well informed about local reactions and transient pain with the injection of C. histolyticum collagenase. Diffusion of this technique is still limited by: the assessment of its cost compared to that of other methods of treatment and particularly the needle fasciotomy, and the evaluation of results over the long-term.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Brides de collagène; Clostridium histolyticum collagenase; Collagen cords; Collagénase de Clostridium histolyticum; Digital retraction; Dupuytren's disease; Maladie de Dupuytren; Rétraction digitale

Mesh:

Substances:

Year:  2013        PMID: 23856551     DOI: 10.1016/j.main.2013.05.004

Source DB:  PubMed          Journal:  Chir Main        ISSN: 1297-3203


  1 in total

1.  Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: report of 40 cases.

Authors:  F Alberton; M Corain; A Garofano; L Pangallo; A Valore; V Zanella; R Adani
Journal:  Musculoskelet Surg       Date:  2013-11-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.